Close

Bora Pharmaceuticals is Awarded Outstanding Company of the Year at Bio-Asia Taiwan 2023

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Related stories

Axtria Scales Forward Deployed Engineering Team to 1,000 Experts

Global data analytics provider Axtria Inc. announced plans on...

FDA Releases Proposed Commitment Letter for Next Generic Drug User Fee Agreement

Following months of negotiations with industry stakeholders, the US...

Buying Guide: How to Source High-Quality Selank for Research

Peptide research continues to expand across academic and independent...
- Advertisement -

July 27, 2023

Bio-Asia Taiwan Exhibition

Taipei, Taiwan

Bora has been awarded “Outstanding Company of the Year” by an independent panel of international judges during Bio-Asia Taiwan exhibit taking place in Taipei, Taiwan July 24-26, 2023. Bora was chosen from a short list of several candidates for its demonstrated leadership in the Taiwan Biopharma industry.

Bobby Sheng said; “Our team’s focused dedication to excellence in quality and customer service continues to be acknowledged by our clients and in BioPharma industry. I’m especially proud of our biologic subsidiary, Bora Biologics, for growing at such a rapid pace and being recognized in the Biopharma community.” 

Bora is currently the only CDMO in Taiwan that has a leading position in both small and large molecules with 6 manufacturing sites with over 70 Billion NTD market cap.

https://boracdmo.com/news-and-events/bora-pharmaceuticals-is-awarded-outstanding-company-of-the-year-at-bio-asia-taiwan-2023/

Company: BORA PHARMACEUTICAL SERVICES INC.


Bora Pharmaceuticals and our group of companies is a publicly-traded company on the Taiwan Stock Exchange (6472). We are Taiwan's largest CDMO with a 50-year history in the Pharmaceutical Industry. We supply drugs to over 100 countries in the world, including the US/Canada, EU, Southeast Asia, Middle East, and South and Central America. We provide outsourced R&D, CDMO, and CMO services for global pharmaceutical companies around the world.

Send Enquiry for this story

By submitting this form you agree to allow www.worldpharmatoday.com to contact you regarding your enquiry.
See our Privacy Policy to learn more.

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast – stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Latest stories

Related stories

Axtria Scales Forward Deployed Engineering Team to 1,000 Experts

Global data analytics provider Axtria Inc. announced plans on...

FDA Releases Proposed Commitment Letter for Next Generic Drug User Fee Agreement

Following months of negotiations with industry stakeholders, the US...

Buying Guide: How to Source High-Quality Selank for Research

Peptide research continues to expand across academic and independent...

CSPC Pharmaceutical and AstraZeneca form Biologics Joint Venture

CSPC Pharmaceutical and AstraZeneca have signed a joint venture...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »